Andrea L. Gropman, M.D.

  • Interim Director, Center for Genetic Medicine Research
  • Chief, Neurogenetics and Neurodevelopmental Pediatrics
  • Attending Neurologist
    • B.A., Biology, Biochemistry, Brandeis University, Waltham, MA, (1982-1985)
    • M.D., Medicine, University of Massachusetts Medical School, Worcester, MA, (1988-1992)
    • Residency, Pediatrics, Johns Hopkins Hospital, Baltimore, MD, (1992-1994)
    • Fellowship, Neurology, George Washington University/Children's National Medical Center, Washington, DC, (1994-1997)
    • Post-doctoral, Genetics, Biochemical Genetics, National Institutes of Health, Human Genome Research Institute, Bethesda, MD, (1997-2000)
  • Andrea Gropman, M.D., FAAP, FACMG, FANA, is the principal investigator of the Urea Cycle Disorders Consortium (UCDC) and the UCDC imaging consortium. She is the deputy clinical director of the Mito EpiGen Program, as well as a Margaret O’Malley professor of genetic medicine. Her research interest focuses on establishing biomarkers of neurological injury in patients with inborn errors of metabolism, such as urea cycle disorders and mitochondrial disorders, using specialized neuroimaging modalities and cell markers.